| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C010914 |
2,4-diaminotoluene |
2,4-diaminotoluene results in increased expression of ESPL1 mRNA | increases expression | 20713471
|
| D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ESPL1 mRNA | decreases expression | 20382639 19150397
|
| D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of ESPL1 mRNA | decreases expression | 20106945
|
| D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of ESPL1 mRNA | increases expression | 17942748
|
| D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ESPL1 mRNA | affects cotreatment|increases expression | 17942748
|
| D005472 |
Fluorouracil |
ESPL1 protein affects the susceptibility to Fluorouracil | affects response to substance | 15548681
|
| D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of ESPL1 mRNA | increases expression | 20713471
|
| C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ESPL1 mRNA | affects binding|increases activity|increases expression | 19710929
|
| D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ESPL1 mRNA | affects cotreatment|increases expression | 17942748
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.18 | 15322242 14514962 11752688 |
| MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.32 | 17505938 |
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.38 | 18653653 |
| MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.51 | 14692618 |
| MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.51 | 17638652 |
| MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
3.62 | 10545420 6695378 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
11.05 | 16434500 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
11.05 | 16835633 |
| MESH:D000740 |
Anemia |
|
Fluorouracil |
9.45 | 17963324 15504547 16511603 |
| MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
9.45 | 11748828 |
| MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.77 | 11256880 |
| MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.80 | 15885639 |
| MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.58 | 11922910 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.59 | 19483382 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.59 | 12125929 |
| MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.17 | 15340226 |
| MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.91 | 15746008 |
| MESH:D001943 |
Breast Neoplasms |
|
2,4-diaminotoluene |
2.05 | 11921183 |
| MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.05 | 16595493 19217205 16557594 16110121 18357371 15136595 18608205 |
| MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
2.05 | 17474063 |
| MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.05 | 20435547 |
| MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
5.04 | 16051944 |
| MESH:D002277 |
Carcinoma |
|
Fluorouracil |
15.14 | 17121937 |
| MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
15.14 | 10545420 |
| MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
15.14 | 16835633 |
| MESH:D003528 |
Carcinoma, Adenoid Cystic |
marker/mechanism |
|
| 16762588 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
2.11 | 17045692 17088986 16332177 17971768 16799960 18930000 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.11 | 18695887 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
2.55 | 18986760 16757204 16280240 17066447 |
| MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.49 | 18850075 18670907 16120746 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
12.18 | 20889678 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
12.18 | 12371664 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
12.18 | 16192471 |
| MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.38 | 16835633 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
14.38 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
14.38 | 17681005 17110522 16105132 15861022 16919318 17333356 11677210 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
14.38 | 19176532 |
| MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.19 | 12621046 8697196 16354765 15668235 15340226 |
| MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.26 | 17169374 16510598 17018589 17725105 17016597 15001691 18772588 17287894 17172411 16340194 |
| MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.00 | 18509181 20501625 16303861 14970324 18383874 18949393 16282729 17401013 17695437 16391804 15148649 15289873 16524972 16331619 17454858 18288408 18802399 17255274 17594712 17094418 18448328 17016601 |
| MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 17141729 14669216 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 20055451 10048152 |
| MESH:D007644 |
Darier Disease |
|
Fluorouracil |
5.13 | 16733453 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.52 | 18249437 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.59 | 20420201 |
| MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.93 | 11462148 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
7.35 | 12083418 |
| MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.35 | 12711302 11000095 |
| MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.28 | 15322242 18230668 16714409 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.47 | 12538720 |
| MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.25 | 9294722 10568697 |
| MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.68 | 20426865 |
| MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.68 | 15173087 16481741 16337965 16785472 17638652 |
| MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.19 | 11564622 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
14.46 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
14.46 | 15345470 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
14.46 | 20131406 19236843 |
| MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.76 | 11858732 |
| MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
5.28 | 10962813 14633661 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.52 | 12168785 12639820 |
| MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
9.52 | 20067830 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.56 | 8708960 |
| MESH:D005910 |
Glioma |
|
Fluorouracil |
2.95 | 16145905 |
| MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.97 | 10696789 |
| MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.54 | 18337622 15102660 15162350 |
| MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.44 | 11294989 10048152 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.67 | 20558911 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.76 | 15720958 |
| MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.58 | 11000095 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.30 | 19176532 16221962 19772884 18467677 |
| MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.30 | 16120746 15340226 12621046 |
| MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.42 | 8697196 16959395 16354765 18606429 15340226 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.41 | 20558911 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.21 | 10903974 |
| MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.21 | 18850075 18670907 |
| MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.12 | 16569931 16945680 |
| MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.72 | 12013081 |
| MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.64 | 17937319 |
| MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.96 | 12878042 12200463 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.78 | 16306350 |
| MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.58 | 16580747 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.82 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.46 | 18776723 10903974 8314463 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
8.07 | 12371664 |
| MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
8.07 | 16985049 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.19 | 15474484 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.19 | 12878042 |
| MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
7.83 | 16603448 17045692 15113037 18383874 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.83 | 15890375 20007298 16377806 |
| MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.83 | 16984957 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
6.47 | 598648 1399818 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
6.47 | 12151625 |
| MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
3.61 | 15246190 |
| MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
3.61 | 16337739 9230183 15390079 10545420 20970405 11893704 16271038 7750092 21163286 1399818 6695378 20512841 17909032 |
| MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.61 | 11884234 19555203 |
| MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
5.13 | 15086387 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
2,4-diaminotoluene |
3.72 | 11921183 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.16 | 16801185 |
| MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.81 | 16757204 18986760 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.81 | 16239165 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.22 | 19151258 |
| MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.21 | 12213967 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.13 | 16411023 |
| MESH:D009369 |
Neoplasms |
|
Fluorouracil |
5.34 | 16928823 18600527 18239605 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.34 | 17405874 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.82 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.50 | 18481113 19348381 |
| MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.49 | 14600291 |
| MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.59 | 16436463 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.86 | 20558911 |
| MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.73 | 19003803 16929163 16500647 15113037 |
| MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.95 | 11578682 |
| MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.62 | 12520081 |
| MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.84 | 18163543 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.44 | 12371664 |
| MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.53 | 11399792 11222880 11896295 11118676 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.37 | 18626508 19082440 |
| MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.65 | 15861022 16919318 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.30 | 16882103 |
| MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.23 | 18286688 15538739 16160472 18722050 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.49 | 19058328 |
| MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.12 | 18990726 |
| MESH:D012468 |
Salivary Gland Neoplasms |
marker/mechanism |
|
| 16762588 |
| MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.14 | 16192470 |
| MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.32 | 16709447 |
| MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.00 | 17522103 17498489 18396642 15786421 16424979 17172411 18567086 19084572 19015929 16951190 |
| MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.88 | 11994571 |
| MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.37 | 15669648 |
| MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.28 | 12697716 |
| MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
4.22 | 16280240 |
| MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
4.11 | 16803524 |
| MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.58 | 14692618 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.36 | 1336536 |
| MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.97 | 12125929 |
| MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.78 | 14671159 15869587 |
| MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.62 | 15886252 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.82 | 17120751 |